RxDoctor Payments Data

Fred Clark, MD

Family Medicine · Saint Petersburg, FLNPI 1609022086

Payments from drug & device makers

$4,662in general payments, 2019–2025

Across 272 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$797
  • AstraZeneca$612
  • GSK$493
  • Novo Nordisk$442
  • Amgen$436
  • Lilly USA, LLC$310
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$4,59699%
  • Education$661%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,662 in reported general payments places this provider in the 85th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$459,947
Medicare patients
215
Services billed
5,632

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide53$94,114
OzempicSemaglutide40$67,305
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$64,871
EliquisApixaban51$60,241
TrulicityDulaglutide51$55,764
BiktarvyBictegrav/Emtricit/Tenofov Ala12$55,369
FarxigaDapagliflozin Propanediol23$24,344
XareltoRivaroxaban16$18,856
MyrbetriqMirabegron15$13,381
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen140$7,996
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen101$3,593
Rosuvastatin Calcium193$3,436
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine19$2,189
Gabapentin93$2,142
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine62$1,976

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$310$149,878104 claims
Novo NordiskOzempic$442$67,30540 claims
GSKTrelegy Ellipta$493$64,87144 claims
PfizerEliquis$146$60,24151 claims
AstraZenecaFarxiga$612$24,34423 claims
Astellas Pharma US IncMyrbetriq$214$13,38115 claims
AbbVieSynthroid$797$1,65025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Saint Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →